-
1
-
-
70349371112
-
A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms
-
Baron R., Tölle T.R., Gockel U., Brosz M., and Feynhagen R. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms. Pain 146 (2009) 34-40
-
(2009)
Pain
, vol.146
, pp. 34-40
-
-
Baron, R.1
Tölle, T.R.2
Gockel, U.3
Brosz, M.4
Feynhagen, R.5
-
2
-
-
37849031855
-
Tramadol and several anticonvulsants synergize in attenuating nerve injury-induced allodynia
-
Codd E.E., Martinez R.P., Molino L., Rogers K.E., Stone D.J., and Tallarida R.J. Tramadol and several anticonvulsants synergize in attenuating nerve injury-induced allodynia. Pain 134 (2008) 254-262
-
(2008)
Pain
, vol.134
, pp. 254-262
-
-
Codd, E.E.1
Martinez, R.P.2
Molino, L.3
Rogers, K.E.4
Stone, D.J.5
Tallarida, R.J.6
-
3
-
-
67649435616
-
A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain
-
Daniels S., Casson E., Stegmann J.U., Oh C., Okamoto A., Rauschkolb C., and Upmalis D. A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain. Curr. Med. Res. Opin. 25 (2009) 1551-1561
-
(2009)
Curr. Med. Res. Opin.
, vol.25
, pp. 1551-1561
-
-
Daniels, S.1
Casson, E.2
Stegmann, J.U.3
Oh, C.4
Okamoto, A.5
Rauschkolb, C.6
Upmalis, D.7
-
4
-
-
67649378979
-
A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain
-
Daniels S.E., Upmalis D., Okamoto A., Lange C., and Haeussler J. A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain. Curr. Med. Res. Opin. 25 (2009) 765-776
-
(2009)
Curr. Med. Res. Opin.
, vol.25
, pp. 765-776
-
-
Daniels, S.E.1
Upmalis, D.2
Okamoto, A.3
Lange, C.4
Haeussler, J.5
-
5
-
-
0034079572
-
Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group
-
Dyck P.J., Dyck P.J.B., Larson T.S., O'Brien P.C., and Velosa J.A. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care 23 (2000) 510-517
-
(2000)
Diabetes Care
, vol.23
, pp. 510-517
-
-
Dyck, P.J.1
Dyck, P.J.B.2
Larson, T.S.3
O'Brien, P.C.4
Velosa, J.A.5
-
6
-
-
70350482812
-
Efficacy and safety of tapentadol ER for diabetic peripheral neuropathic pain: results of a randomized-withdrawal, double-blind, placebo-controlled phase III study
-
Etropolski M., Shapiro D.Y., Okamoto A., Rauschkolb C., and Haeussler J. Efficacy and safety of tapentadol ER for diabetic peripheral neuropathic pain: results of a randomized-withdrawal, double-blind, placebo-controlled phase III study. Neurology 72 11 Suppl. 3 (2009) A217-A218
-
(2009)
Neurology
, vol.72
, Issue.11 SUPPL. 3
-
-
Etropolski, M.1
Shapiro, D.Y.2
Okamoto, A.3
Rauschkolb, C.4
Haeussler, J.5
-
7
-
-
0033030274
-
Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat
-
Field M.J., McCleary S., Hughes J., and Singh L. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 80 (1999) 391-398
-
(1999)
Pain
, vol.80
, pp. 391-398
-
-
Field, M.J.1
McCleary, S.2
Hughes, J.3
Singh, L.4
-
8
-
-
43549096159
-
Supra-additive effects of tramadol and acetaminophen in a human pain model
-
Filitz J., Ihmsen H., Gunther W., Troster A., Schwilden H., Schuttler J., and Koppert W. Supra-additive effects of tramadol and acetaminophen in a human pain model. Pain 136 (2008) 262-270
-
(2008)
Pain
, vol.136
, pp. 262-270
-
-
Filitz, J.1
Ihmsen, H.2
Gunther, W.3
Troster, A.4
Schwilden, H.5
Schuttler, J.6
Koppert, W.7
-
9
-
-
67649414317
-
Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study
-
Hale M., Upmalis D., Okamoto A., Lange C., and Rauschkolb C. Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study. Curr. Med. Res. Opin. 25 (2009) 1095-1104
-
(2009)
Curr. Med. Res. Opin.
, vol.25
, pp. 1095-1104
-
-
Hale, M.1
Upmalis, D.2
Okamoto, A.3
Lange, C.4
Rauschkolb, C.5
-
10
-
-
62149094353
-
Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study
-
Hartrick C., Van Hove I., Stegmann J.-U., Oh C., and Upmalis D. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study. Clin. Ther. 31 (2009) 260-271
-
(2009)
Clin. Ther.
, vol.31
, pp. 260-271
-
-
Hartrick, C.1
Van Hove, I.2
Stegmann, J.-U.3
Oh, C.4
Upmalis, D.5
-
11
-
-
33750396100
-
New perspectives on the management of diabetic peripheral neuropathic pain
-
Jensen T.S., Backonja M.M., Hernandez J.S., Tesfaye S., Valensi P., and Ziegler D. New perspectives on the management of diabetic peripheral neuropathic pain. Diab. Vasc. Dis. Res. 3 (2006) 108-119
-
(2006)
Diab. Vasc. Dis. Res.
, vol.3
, pp. 108-119
-
-
Jensen, T.S.1
Backonja, M.M.2
Hernandez, J.S.3
Tesfaye, S.4
Valensi, P.5
Ziegler, D.6
-
12
-
-
0026536643
-
Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonists
-
Kamei J., Ohhashi Y., Aoki T., Kawasima N., and Kasuya Y. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonists. Brain Res. 571 (1992) 199-203
-
(1992)
Brain Res.
, vol.571
, pp. 199-203
-
-
Kamei, J.1
Ohhashi, Y.2
Aoki, T.3
Kawasima, N.4
Kasuya, Y.5
-
13
-
-
28844493645
-
Peripheral axonal injury results in reduced μ opioid receptor pre- and post-synaptic action in the spinal cord
-
Kohno T., Ji R.R., Ito N., Allchorne A.J., Befort K., Karchewski L.A., and Woolf C.J. Peripheral axonal injury results in reduced μ opioid receptor pre- and post-synaptic action in the spinal cord. Pain 117 (2005) 77-87
-
(2005)
Pain
, vol.117
, pp. 77-87
-
-
Kohno, T.1
Ji, R.R.2
Ito, N.3
Allchorne, A.J.4
Befort, K.5
Karchewski, L.A.6
Woolf, C.J.7
-
14
-
-
65549124387
-
Anti-nociceptive effect of duloxetine in mouse model of diabetic neuropathic pain
-
Kuhad A., Bishnoi M., and Chopra K. Anti-nociceptive effect of duloxetine in mouse model of diabetic neuropathic pain. Indian J. Exp. Biol. 47 (2009) 193-197
-
(2009)
Indian J. Exp. Biol.
, vol.47
, pp. 193-197
-
-
Kuhad, A.1
Bishnoi, M.2
Chopra, K.3
-
15
-
-
0037448104
-
The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid system
-
Marchand F., Alloui A., Chapuy E., Hernandez A., Pelissier T., Ardid D., and Eschalier A. The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid system. Neurosci. Lett. 342 (2003) 105-108
-
(2003)
Neurosci. Lett.
, vol.342
, pp. 105-108
-
-
Marchand, F.1
Alloui, A.2
Chapuy, E.3
Hernandez, A.4
Pelissier, T.5
Ardid, D.6
Eschalier, A.7
-
16
-
-
0026522154
-
Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy
-
Max M.B., Lynch S.A., Muir J., Shoaf S.E., Smoller B., and Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N. Engl. J. Med. 326 (1992) 1250-1256
-
(1992)
N. Engl. J. Med.
, vol.326
, pp. 1250-1256
-
-
Max, M.B.1
Lynch, S.A.2
Muir, J.3
Shoaf, S.E.4
Smoller, B.5
Dubner, R.6
-
17
-
-
0036277865
-
Descending control of pain
-
Millan M.J. Descending control of pain. Prog. Neurobiol. 66 (2002) 355-474
-
(2002)
Prog. Neurobiol.
, vol.66
, pp. 355-474
-
-
Millan, M.J.1
-
18
-
-
0028858069
-
Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury
-
Ossipov M.H., Lopez Y., Nichols M.L., Bian D., and Porreca F. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury. Neurosci. Lett. 199 (1995) 83-86
-
(1995)
Neurosci. Lett.
, vol.199
, pp. 83-86
-
-
Ossipov, M.H.1
Lopez, Y.2
Nichols, M.L.3
Bian, D.4
Porreca, F.5
-
19
-
-
0344064091
-
Systematic review of antidepressants in the treatment of chronic low back pain
-
Staiger T.O., Gaster B., Sullivan M.D., and Deyo R.A. Systematic review of antidepressants in the treatment of chronic low back pain. Spine 28 (2003) 2540-2545
-
(2003)
Spine
, vol.28
, pp. 2540-2545
-
-
Staiger, T.O.1
Gaster, B.2
Sullivan, M.D.3
Deyo, R.A.4
-
20
-
-
34548831995
-
(-)-(1R, 2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel μ opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties
-
Tzschentke T.M., Christoph T., Kögel B., Schiene K., Hennies H.-H., Englberger W., Haurand M., Jahnel U., Cremers T.I., Friderichs E., and De Vry J. (-)-(1R, 2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel μ opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties. J. Pharmacol. Exp. Ther. 323 (2007) 265-276
-
(2007)
J. Pharmacol. Exp. Ther.
, vol.323
, pp. 265-276
-
-
Tzschentke, T.M.1
Christoph, T.2
Kögel, B.3
Schiene, K.4
Hennies, H.-H.5
Englberger, W.6
Haurand, M.7
Jahnel, U.8
Cremers, T.I.9
Friderichs, E.10
De Vry, J.11
-
21
-
-
33847027978
-
Tapentadol HCl
-
Tzschentke T.M., De Vry J., Terlinden R., Hennies H.H., Lange C., Strassburger W., Haurand M., Kolb J., Schneider J., Buschmann H., Finkam M., Jahnel U., and Friderichs E. Tapentadol HCl. Drugs Future 31 (2006) 1053-1061
-
(2006)
Drugs Future
, vol.31
, pp. 1053-1061
-
-
Tzschentke, T.M.1
De Vry, J.2
Terlinden, R.3
Hennies, H.H.4
Lange, C.5
Strassburger, W.6
Haurand, M.7
Kolb, J.8
Schneider, J.9
Buschmann, H.10
Finkam, M.11
Jahnel, U.12
Friderichs, E.13
-
22
-
-
71249138937
-
Tapentadol hydrochloride: a next-generation, centrally acting analgesic with two mechanisms of action in a single molecule
-
Tzschentke T.M., Jahnel U., Kogel B., Christoph T., Englberger W., De V.J., Schiene K., Okamoto A., Upmalis D., Weber H., Lange C., Stegmann J.U., and Kleinert R. Tapentadol hydrochloride: a next-generation, centrally acting analgesic with two mechanisms of action in a single molecule. Drugs Today (Barc) 45 (2009) 483-496
-
(2009)
Drugs Today (Barc)
, vol.45
, pp. 483-496
-
-
Tzschentke, T.M.1
Jahnel, U.2
Kogel, B.3
Christoph, T.4
Englberger, W.5
De, V.J.6
Schiene, K.7
Okamoto, A.8
Upmalis, D.9
Weber, H.10
Lange, C.11
Stegmann, J.U.12
Kleinert, R.13
-
23
-
-
50349092303
-
Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options
-
Veves A., Backonja M., and Malik R.A. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 9 (2008) 660-674
-
(2008)
Pain Med.
, vol.9
, pp. 660-674
-
-
Veves, A.1
Backonja, M.2
Malik, R.A.3
-
24
-
-
0020525719
-
Ethical guidelines for investigations of experimental pain in conscious animals
-
Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110
-
(1983)
Pain
, vol.16
, pp. 109-110
-
-
Zimmermann, M.1
|